Atlas FDA

Predicate Research Report · generated 2026-08-23 · Print / save as PDF · Save to account

GRP · Predicate Candidate Screening

6 FDA 510(k) clearances under this product code; the 50 most recent screened below.

49 daysmedian FDA review time
140 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K884967BACTIGEN(R) H. INFLUENZAE TYPE BArmkel, LLC1989-02-07690
K854490IMMUNOSCAN DIRECT HEMOPHILUS INFLUENZAE TYPE B TESAmerican Micro Scan1985-12-27450
K831525H-FLU B ELISA TESTSeragen Diagnostics, Inc.1983-09-291400
K823348H. INFLUENZA B ANTISERA FOR CIEDiagnostica, Inc.1982-12-28490
K821266BBL DIRECTIGEN MENINGITIS TEST KITBd Becton Dickinson Vacutainer Systems Preanalytic1982-06-01290
K820192HAEMOPHILUS INFLUENZAE TYPE B ANTISERUMHyland Therapeutic Div., Travenol Laboratories1982-03-11450

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda